Latent-period stool proteomic assay of multiple sclerosis model indicates protective capacity of host-expressed protease inhibitors

Abstract excerpt

Diseases are often diagnosed once overt symptoms arise, ignoring the prior latent period when effective prevention may be possible. Experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis, exhibits such disease latency, but the molecular processes underlying this asymptomatic period remain poorly characterized. Gut microbes also influence EAE severity, yet their impact on the latent period...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Protease and Inhibitor Mechanisms
• Share to Research on Leishmaniasis Studies
• Share to vaccines and immunoinformatics approaches